Brian Rockwell

Brian Rockwell is a seasoned professional in quality auditing and compliance, currently serving as a Senior Principal Auditor at Eli Lilly and Company since May 2024. Previously, Brian held the position of Associate Director of Quality Audits at Loxo Oncology at Lilly from January 2023 to May 2024, and worked as Senior Manager of GCLP Quality at CRISPR Therapeutics from September 2021 to January 2023, focusing on quality oversight for clinical trial testing. Brian's earlier experience includes various roles at Sanofi Pasteur, where responsibilities spanned from Senior Quality Manager to Manager of R&D Site Quality Operations, providing comprehensive quality oversight and ensuring compliance with regulatory standards. Brian began the professional journey at West Pharmaceutical Services as a Microbiology Lab Analyst. Academic qualifications include a Bachelor of Arts in Biology from Lycoming College, along with a certification in Secondary Education, Biology from Wellsboro Area High School.